| __timestamp | Dynavax Technologies Corporation | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 11032000 | 214161000 |
| Thursday, January 1, 2015 | 4050000 | 283703000 |
| Friday, January 1, 2016 | 11043000 | 346620000 |
| Sunday, January 1, 2017 | 327000 | 507666000 |
| Monday, January 1, 2018 | 8198000 | 599674000 |
| Tuesday, January 1, 2019 | 35219000 | 1123000000 |
| Wednesday, January 1, 2020 | 46551000 | 729000000 |
| Friday, January 1, 2021 | 439442000 | 810000000 |
| Saturday, January 1, 2022 | 722683000 | 587000000 |
| Sunday, January 1, 2023 | 232284000 | 787647000 |
| Monday, January 1, 2024 | 705138000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, revenue generation is a key indicator of success. Over the past decade, Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation have been vying for dominance. From 2014 to 2023, Ionis Pharmaceuticals consistently outperformed Dynavax, with revenues peaking at approximately $1.12 billion in 2019. In contrast, Dynavax saw a significant surge in 2022, reaching around $723 million, a remarkable increase from its 2017 low of just $327,000.
Ionis Pharmaceuticals maintained a steady growth trajectory, with revenues increasing by over 270% from 2014 to 2023. Meanwhile, Dynavax experienced a dramatic turnaround, particularly from 2020 onwards, with a revenue increase of over 1,500% by 2022. This data highlights the dynamic nature of the biotech industry, where innovation and strategic pivots can lead to substantial financial gains.
Who Generates More Revenue? Merck & Co., Inc. or Ionis Pharmaceuticals, Inc.
Amgen Inc. and Dynavax Technologies Corporation: A Comprehensive Revenue Analysis
Revenue Insights: Gilead Sciences, Inc. and Dynavax Technologies Corporation Performance Compared
Who Generates More Revenue? Alnylam Pharmaceuticals, Inc. or Dynavax Technologies Corporation
Incyte Corporation vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Annual Revenue Comparison: BioMarin Pharmaceutical Inc. vs Ionis Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Sarepta Therapeutics, Inc. vs Dynavax Technologies Corporation
Who Generates More Revenue? Corcept Therapeutics Incorporated or Ionis Pharmaceuticals, Inc.
Who Generates More Revenue? Ionis Pharmaceuticals, Inc. or Alkermes plc
Breaking Down Revenue Trends: Merus N.V. vs Dynavax Technologies Corporation
Comparing Revenue Performance: Ligand Pharmaceuticals Incorporated or Dynavax Technologies Corporation?
Revenue Insights: Dynavax Technologies Corporation and Galapagos NV Performance Compared